AMSACRINE, CYTARABINE AND ETOPOSIDE IN THE TREATMENT OF BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA

被引:0
|
作者
WAHLIN, A
机构
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:199 / 205
页数:7
相关论文
共 50 条
  • [31] RAZOXANE IN TREATMENT OF ACUTE MYELOID-LEUKEMIA
    BHAVNANI, M
    DHIR, K
    DELAMORE, IW
    BRITISH MEDICAL JOURNAL, 1978, 2 (6140): : 801 - 801
  • [32] RAZOXANE IN TREATMENT OF ACUTE MYELOID-LEUKEMIA
    SHAW, D
    TUDHOPE, GR
    BRITISH MEDICAL JOURNAL, 1978, 2 (6144): : 1089 - 1090
  • [33] TREATMENT OF ACUTE MYELOID-LEUKEMIA IN PREGNANCY
    CAVENAGH, JD
    RICHARDSON, DS
    CAHILL, MR
    BERNARD, T
    KELSEY, SM
    NEWLAND, AC
    LANCET, 1995, 346 (8972): : 441 - 442
  • [34] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
    Murphy, Tracy
    Yee, Karen W. L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
  • [35] PHASE-II STUDY OF MITOXANTRONE AND CYTARABINE IN ACUTE MYELOID-LEUKEMIA
    BRITOBABAPULLE, F
    CATOVSKY, D
    SLOCOMBE, G
    NEWLAND, AC
    MARCUS, RE
    GOLDMAN, JM
    GALTON, DAG
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 161 - 163
  • [36] MITOZANTRONE AND HIGH-DOSE CYTARABINE IN ADULT ACUTE MYELOID-LEUKEMIA
    MARCUS, RE
    CATOVSKY, D
    GOLDMAN, JM
    GALTON, DAG
    NEWLAND, AC
    SLOCOMBE, G
    HEGDE, U
    LANCET, 1985, 1 (8442): : 1384 - 1384
  • [37] CHROMOSOMES, AUER RODS AND PROGNOSIS IN ACUTE MYELOID-LEUKEMIA
    BILLSTROM, R
    NILSSON, PG
    MITELMAN, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1988, 40 (03) : 273 - 278
  • [38] DAT (DAUNORUBICIN, CYTARABINE, 6-THIOGUANINE) IN ACUTE MYELOID-LEUKEMIA
    REES, JKH
    HAYHOE, FGJ
    LANCET, 1978, 1 (8078): : 1360 - 1361
  • [39] ACUTE MYELOID-LEUKEMIA TREATED BY AMSACRINE AND CYTOSINE ARABINOSYL - PHASE-II TRIAL
    MARIT, G
    DAVID, B
    REIFFERS, J
    BROUSTET, A
    BULLETIN DU CANCER, 1985, 72 (01) : 37 - 41
  • [40] Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia
    Ozkaynak, MF
    Avramis, VI
    Carcich, S
    Ortega, JA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (06): : 475 - 482